Nov 19 (Reuters) - Gerresheimer AG:
* Sensile Medical, a subsidiary of Gerresheimer AG, has signed a contract with the Swiss biopharma-ceutical company SQ Innovation AG
* Contract is for the development, market launch and mass production of a micro pump for the treatment of edema in heart failure
* Sanofi, on the other hand, has terminated the project with Sensile Medical to develop a micro pump for delivery of insulin to treat diabetes
Source text for Eikon:
Further company coverage:
Gdansk Newsroom
